Queensland COVID-19 research

  • Queensland hospitals begin testing drugs in COVID-19 clinical trial

    April 2020

    Queensland hospitals (see collaborations) have started testing two potential treatments on patients with COVID-19 as part of an international clinical trial involving The University of Queensland. Patients admitted to participating Queensland hospitals after testing positive for the disease were involved in the Australasian COVID-19 Trial (ASCOT) study, being led by the Doherty Institute in Melbourne. Queensland hospitals are working with researchers to help test the effectiveness of an HIV drug and a malaria medication for treating COVID-19 at 11 of the state’s hospitals and Wesley Medical Research. The Royal Brisbane and Womens Hospital pharmacy is approved by the Therapeutics Goods Australia to undertake the packing and distribution of the ASCOT study investigational medications to hospitals across Australia and New Zealand. The randomised response adaptive trial will allow researchers to objectively assess whether patients who receive a specific treatment fare better, worse or the same as patients who receive a different therapy. The ASCOT trial involves 2500 patients at more than 70 hospitals, covering every state and territory of Australia, and 12 hospitals in New Zealand.

Artists in Residence Science Program

Art meets science exhibition

  • About the exhibition

    The 2012–2018 Art meets Science Exhibitions provided an opportunity for artists from across South East Queensland to join the artists participating in the Artist in Residence Science program in showcasing their recent artworks that demonstrate a strong art-science connection. Find out more about the artists and artworks featured in these exhibitions in the 2015-2018 Art meets Science exhibition catalogues.

    Therese Flynn-Clarke - Moths of the Caldera - Opodiphthera eucalypti (Gum Emperor Moth) - made from all natural plant fibres